Coherus BioSciences (United States)

company in Redwood City, United States

CHRS Nasdaq SEC CIK 1512762
Follow Coherus BioSciences (United States) Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $14.3M +23.4% vs same quarter last year
Net income −$39.3M −10.7% vs same quarter last year
EPS, diluted −$0.25 +19.4% vs same quarter last year
Operating cash flow −$34M +26.6% vs same quarter last year
Revenue by quarter
$7.7M
$7.6M
$10.3M
$11.6M
$12.7M
$12.3M
$14.3M
$14.3M
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income15 fiscal years
  • Revenue
  • Net income
−$400M−$200M$0$200M$400M$600MFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25$42.2M$168M
FY24$26.4M$28.5M
FY23$1.2M−$237.9M
FY22$211M−$291.8M
FY21$326.6M−$287.1M
FY20$475.8M$132.2M
FY19$356.1M$89.8M
FY18$0−$209.3M
FY17$1.6M−$238.2M
FY16$189.5M−$127.3M
FY15$30M−$223.3M
FY14$31.1M−$87.1M
FY13$2.8M−$53.6M
FY12$1.9M−$33M
FY11--
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−20000%−15000%−10000%−5000%0%5000%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2567.2%−429.5%398.4%
FY2466.9%−756.6%108%
FY2364%−17716.6%−19531.4%
FY2266.8%−121.7%−138.2%
FY2182.4%−80.8%−87.9%
FY2092.1%32.9%27.8%
FY1995.2%30.3%25.2%
FY18---
FY17-−14918.8%−15306.6%
FY16-−61.2%−67.2%
FY15-−729.2%−743.2%
FY14-−207.9%−280.1%
FY13-−1308.4%−1949.7%
FY12-−2028.3%−1738.7%
FY11---
Free cash flowOperating cash flow minus capital expenditure
−$400M−$200M$0$200MFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25-
FY24-
FY23−$175.2M
FY22−$243.2M
FY21−$38.7M
FY20$146.9M
FY19$26.5M
FY18−$160.1M
FY17−$204.9M
FY16−$259.1M
FY15−$114.2M
FY14−$26.8M
FY13$15.1M
FY12−$20M
FY11-
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Coherus BioSciences (United States)
  • Healthcare median
−20000%−15000%−10000%−5000%0%5000%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearCoherus BioSciences (United States)Healthcare median
FY25398.4%−30.6%
FY24108%−47%
FY23−19531.4%−58%
FY22−138.2%−80.4%
FY21−87.9%−71.9%
FY2027.8%−62.2%
FY1925.2%−46.3%
FY18-−49.6%
FY17−15306.6%−45.9%
FY16−67.2%−36%
FY15−743.2%−38.4%
FY14−280.1%−35.5%
FY13−1949.7%−37.1%
FY12−1738.7%−29.1%
FY11-−27.9%